Where to find us in 2022 and 2023

Exhibitions, congresses and networking events

  • Annarita Miccio, Institut Imagine
    • Future approaches in gene therapy. XIII National congress of the SITE society Rome, Italy, 2023.
    • Editing to increase fetal hemoglobin. 2023 Annual Sickle Cell Disease Research. NIH, US, 2023 (virtual meeting).
    • Genome editing strategies for β-hemoglobinopathies. Sun Pharma Science Foundation’s National Conference “CRISPR and the Clinic: So Near and Yet So Far”, New Delhi, India, 2023 (virtual meeting).
    • Genome editing approaches to β-hemoglobinopathies. COST action CA21113 GenE-Humdi meeting, 2023, Granada, Spain.
    • Gene editing 2.0: base editing and beyond (for sickle cell disease). Third international summit on human genome editing, 2023, London, UK.
    • Genome editing strategies for β-hemoglobinopathies. III Mini Symposium “Innovative Gene Therapy Approaches in Rare Diseases”, 2023, UCL, London, UK.
    • Genome editing approaches to β-hemoglobinopathies. ICPerMed Conference-Prelude to the Future of Medicine, 2022, Paris, France (keynote speaker)

  • Sjaak Philipsen, Erasmus MC
    • ESH 3rd Translational Research Conference ‘Erythropoiesis control and ineffective erythropoiesis: from bench to bedside’, Paris, FR, 3-5 March 2023
    • Screening of ‘Mijn bloed beïnvloedt', a documentary about SCD patients, at Erasmus MC, 8 March 2023
    • Workshop ‘Molecular aspects of normal and malignant hematopoiesis’, Rotterdam, NL, 6-7 June 2023
    • Symposium ‘Curative cell- and gene therapies for Hb-pathies’, Leiden, NL, 29 June 2023 (Sjaak Philipsen speaker in closed part of the symposium)
    • Bi-annual meetings with User Committee for development of HbF activating compounds, and annual meeting with User Committee for development of cellular products for treatment of hemoglobinopathy patients. In these meetings stakeholders, specifically patients, clinicians, biotech companies, venture capital companies and GMP experts are involved.
    • To raise money for SCD research, we participated in the benefit dinner of the Dutch Sickle Cell Foundation (March 2023).
    • We started talks with Vertex Pharmaceuticals (Boston, US) on introduction of genetic therapy in The Netherlands (Cas9 RNPs targeting the BCL11A enhancer ex vivo) (May 2023)
    • We are part of a new national Dutch academic initiative to develop genetic therapy for SCD patients (June 2023)

  • Filippo Del Bene, SU 

    • First French zebrafish meeting. Keynote lecture on disease models in zebrafish and genome editing. Montpellier France 2023
    • Workshop Pisa zebrafish day. Keynote lecture on disease models in zebrafish and genome editing. Pisa Italy 2023
    • Fund raising event with FRM (Fondation pour la recherche Médicale) Modeling of neurodegenerative diseases in zebrafish. June 2023 Paris, France

  • ZeClinics
    • Invited talk (Vincenzo Di Donato) on Zebrafish genetics. October 2022. Istituto San Raffaele, Milan, Italy.
    •  https://www.zeclinics.com/news/zeclinics-has-been-granted-e1m-from-the-eic-pathfinder-challenge-for-the-edigent-project-to-develop-new-technologies-applied-to-gene-therapy/.
    •  https://www.zeclinics.com/science/edigent-new-prime-editing-and-non-viral-delivery-strategies-for-gene-therapy/.

  • Inserm
    • Recent developments of Genome editing approaches and applications in therapy.  Clinic Research day, Nov 2022, Academie de chirurgie, Paris
    • Precise genome editing: how to get it better ? Tribute day to JS Joly, Nov 2023, Saclay
    • TREND (Teaching and Research in Natural Sciences for Development in Africa) courses in genome editing: Midlands University, Gweru, Zimbabwe, 2022